Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Breakthrough Drug Introduced to Treat Primary Hyperoxaluria Type 1
Dicerna Pharmaceuticals announced that its investigational drug, DCR-PHXC is used for the treatment of patients with primary hyperoxaluria type 1 (PH1), a rare genetic liver disorder that often results in kidney failure....
PanTheryx to Launch New Anti-Diarrheal Product In Cambodia
US-based biotechnology company, PanTheryx, in partnership with Zuellig Pharma, a healthcare company in Asia, announced the launch of innovation of DiaResQ for diarrhea relief in Cambodia....
University of Otago Discovered New Drugs to Treat Top Infectious Disease
University of Otago researchers have discovered a novel property of a new anti-tuberculosis drug which may help develop more drugs to treat the top infectious killer disease in the world. Bedaquiline is the first new drug to be developed after 40 years for more effective combat against TB....
WVU Researchers Map Crystals to Enhance Advance Therapies for Stroke, Diabetes, and Dementia
West Virginia University researchers mapped the crystal structure of the protein and located how a drug fixes on it. Researchers revealed how medications are attached to the proteins in our body, how they work and what form they acquire....
World's Fist-of-its-Kind Drug Delivery Device Launched for Precise Dosing of Cannabis
In Israel, Syqe Medical has launched the world's first metered-dose cannabis inhaler that meets pharmaceutical standards....
UIC's Scientists Develop a Novel Device to Screen Advanced Crystalline Materials
Researchers and scientists at the University of Illinois at Chicago and AbbVie Inc. developed a novel device to screen and test formation of drug substance-Active Pharmaceutical Ingredient (API)....
Bayer Launches Breakthrough Therapy AliqopaTM (Copanlisib) for Treatment of Marginal Zone Lymphoma
Aliqopa (Copanlisib) is administered intravenously and exhibits inhibitory activity against phosphatidylinositol-3-Kinase (PL3K), primarily targeting the PL3K-alpha and PL3K-delta isoforms expressed in malignant B cells....
Harvard Chemist's Developed Synthesis Advance Potent Anti-Malignant Tumour Agent
Harvard University chemist's synthesis of halichondrin is known to be a potent anti-cancer agent. Harvard University Chemists have achieved a landmark in drug discovery spending three decades in making it....
Novel Agent Reactivates an Immune Call by LIF Blockade
A groundbreaking therapy known as the novel agent reactivates has emerged, offering a dual mechanism of action to effectively eradicate malignant stem cells and stimulate the immune system....
A 3D-Printed Clinical Device Intended to Detect Biomarkers of Preterm Birth
The 3D-Printed device is a microchip electrophoresis device that can sensitively detect three serum biomarkers of Preterm birth (PTB)....
